<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>Studies of alogliptin for lowering blood glucose concentration in patients with type II diabetes — alog_pcfb • MBNMAdose</title><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous"><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><meta property="og:title" content="Studies of alogliptin for lowering blood glucose concentration in patients with type II diabetes — alog_pcfb"><meta property="og:description" content="A dataset from a systematic review of Randomised-Controlled Trials (RCTs) comparing different doses of
alogliptin with placebo (Langford et al. 2016)
. The systematic review was simply performed and was intended to
provide data to illustrate a statistical methodology rather than for clinical inference. Alogliptin is
a treatment aimed at reducing blood glucose concentration in type II diabetes. The outcome is continuous,
and aggregate data responses correspond to the mean change in HbA1c from baseline to follow-up in studies
of at least 12 weeks follow-up. The dataset includes 14 Randomised-Controlled Trials (RCTs), comparing 5
different doses of alogliptin with placebo, leading to 6 different treatments (combination of dose and agent)
within the network."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body data-spy="scroll" data-target="#toc">
    

    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">MBNMAdose</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.4.2.900</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu"><li>
      <a href="../articles/mbnmadose.html">MBNMAdose for dose-response Model-Based Network Meta-Analysis</a>
    </li>
  </ul></li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"></ul></div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Studies of alogliptin for lowering blood glucose concentration in patients with type II diabetes</h1>
    
    <div class="hidden name"><code>alog_pcfb.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>A dataset from a systematic review of Randomised-Controlled Trials (RCTs) comparing different doses of
alogliptin with placebo (Langford et al. 2016)
. The systematic review was simply performed and was intended to
provide data to illustrate a statistical methodology rather than for clinical inference. Alogliptin is
a treatment aimed at reducing blood glucose concentration in type II diabetes. The outcome is continuous,
and aggregate data responses correspond to the mean change in HbA1c from baseline to follow-up in studies
of at least 12 weeks follow-up. The dataset includes 14 Randomised-Controlled Trials (RCTs), comparing 5
different doses of alogliptin with placebo, leading to 6 different treatments (combination of dose and agent)
within the network.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">alog_pcfb</span></span></code></pre></div>
    </div>

    <div id="format">
    <h2>Format</h2>
    <p>A data frame in long format (one row per arm and study), with 46 rows and 6 variables:</p><ul><li><p><code>studyID</code> Study identifiers</p></li>
<li><p><code>agent</code> Character data indicating the agent to which participants were randomised</p></li>
<li><p><code>dose</code> Numeric data indicating the standardised dose received</p></li>
<li><p><code>y</code> Numeric data indicating the mean change from baseline in blood glucose concentration (mg/dL) in a study arm</p></li>
<li><p><code>se</code> Numeric data indicating the standard error for the mean change from baseline in blood glucose concentration (mg/dL) in a study arm</p></li>
<li><p><code>n</code> Numeric data indicating the number of participants randomised</p></li>
</ul></div>
    <div id="details">
    <h2>Details</h2>
    <p><code>alog_pcfb</code> is a data frame in long format (one row per arm and study), with the variables <code>studyID</code>, <code>agent</code>, <code>dose</code>, <code>y</code>, <code>se</code>, and <code>N</code>.</p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>Langford O, Aronson JK, van Valkenhoef G, Stevens RJ (2016).
“Methods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptin.”
<em>Stat Methods Med Res</em>.
ISSN 1477-0334 (Electronic) 0962-2802 (Linking), <a href="https://doi.org/10.1177/0962280216637093" class="external-link">doi:10.1177/0962280216637093</a>
, <a href="https://journals.sagepub.com/doi/10.1177/0962280216637093" class="external-link">https://journals.sagepub.com/doi/10.1177/0962280216637093</a>.</p>
    </div>

  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Hugo Pedder.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.6.</p>
</div>

      </footer></div>

  


  

  </body></html>

